ArticleJournal of diabetes2026
Impact of Cardiometabolic Risk Markers on the Incidence and Progression Arterial Stiffness in Patients With Prediabetes.
Article in Journal of diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPrevious studies have reported that insulin resistance (IR), blood pressure, body mass index (BMI), and dyslipidemia are associated with arterial stiffness. However, limited evidence exists regarding these relationships in prediabetes patients. The purpose of this study was to investigate the longitudinal associations between cardiometabolic risk markers and progression of arterial stiffness.
methodsThis study included 5771 adults with prediabetes at baseline from the Shougang cohort study. Cardiometabolic risk markers included the triglyceride glucose (TyG) index, triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, mean arterial pressure (MAP), BMI, and dyslipidemia. Arterial stiffness was assessed using brachial-ankle pulse wave velocity (baPWV), and its progression was defined as the annual change in baPWV between baseline and the last visit. Multivariate linear and logistic regression models were used to investigate the associations.
resultsMultivariate linear regression analyses showed TyG index, TG/HDL-C ratio, MAP, and dyslipidemia were significantly associated with baseline baPWV. Over a mean follow-up of 3.24 years, each one-unit increase in the MAP was significantly associated with a faster progression of baPWV (difference, 0.72 cm/s per year; 95% CI, 0.40 to 1.04 cm/s per year). After adjusting for all covariates, the risk for arterial stiffness increased 3% with each one-unit increase of MAP.
conclusionAmong individuals with prediabetes, MAP showed consistent longitudinal associations with arterial stiffness, highlighting the importance of early blood pressure management for vascular protection prior to the onset of diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.